Prof. Dr. Friedrich Jung | Radiologie | Best Researcher Award

Brandenburg University of Technology | Germany

Prof. Dr. Friedrich Jung is a distinguished molecular cell biologist and biomedical engineer whose research has profoundly influenced the fields of biomaterials, hemorheology, and regenerative medicine. He currently serves in an advisory capacity at the Technical University of Brandenburg, following a prolific tenure as Head of the Department of Biointerface Engineering at the Center for Biomaterial Development and the Berlin Brandenburg Center for Regenerative Therapies (BCRT). Over his illustrious career, Dr. Jung has produced an extensive body of work comprising 684 peer-reviewed publications, 216 book chapters, and 16 edited or co-edited volumes, reflecting his exceptional scientific productivity. His research has earned him an impressive h-index of 44, supported by over 10,106 citations and more than 554 scientific documents, underscoring the global impact of his scholarly contributions. Dr. Jung’s pioneering studies have advanced understanding in areas such as biomaterial hemocompatibility, tissue engineering, and endothelial cell biology. Notable works include investigations into thrombogenicity testing of biomaterials, endothelialization of hydrophobic polymers, and metabolic modeling using CYP-overexpressing cell lines. Recognized internationally, he has been honored with prestigious awards such as the Robin Fahraeus Award, the Otfried-Müller Award, and the Oskar Orth Award, reflecting his outstanding contributions to biomedical science and clinical hemorheology.

Profiles: Scopus | Orcid | Research Gate

Featured Publications

Jung, F., et al. High-resolution contrast-enhanced ultrasound with SRCEUS for assessing the intrahepatic microvasculature and shunts in patients with hereditary haemorrhagic teleangiectasia (Osler’s disease). Life.

Jung, F., et al.  Super-resolution contrast-enhanced ultrasound examination down to the microvasculature enables quantitative analysis of liver lesions: First results. Life.

Schulz, C., Stegen, S., Jung, F., & Küpper, J.-H. Mono-CYP CHO model: A recombinant Chinese hamster ovary cell platform for investigating CYP-specific tamoxifen metabolism. International Journal of Molecular Sciences, 26(9),

Jung, F., et al. Intraoperative contrast-enhanced ultrasound (CEUS) with time intensity curve (TIC) analysis for better assessment of liver tumor margins.

Friedrich Jung | Radiologie | Best Researcher Award

You May Also Like